D-0605-2018 Class III Terminated

Recalled by Renaissance Lakewood, LLC — Lakewood, NJ

FDA drug recall D-0605-2018 was initiated by Renaissance Lakewood, LLC on Mar 2, 2018 and is designated Class III. Reason for recall: Superpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeability The recall status is terminated (terminated Apr 10, 2020). Affected quantity: 1277 bags.

Recall details

Product Type
Drugs
Report Date
Apr 4, 2018
Initiation Date
Mar 2, 2018
Termination Date
Apr 10, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1277 bags

Product description

Flucanazole Injection, USP 200 mg in in 100 mL (2 mg/mL), 10 Single Dose Flexible Containers, Rx Only, Manufactured for: Claris Lifesciences, Inc. North Brunswick, NJ 08902 By; Claris Injectables Ltd. Gujarat, India --- NDC 36000-006-10

Reason for recall

Superpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeability

Distribution pattern

Nationwide

Code information

Lot A060644, May 2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0605-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0605-2018. Report a data issue: hello@regdatalab.com.